Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (192${count})

  • Cognition Biomarkers, 2013
    [18F]flubatine: A Novel Biomarker of Cognition in Parkinson's Disease

    Objective/Rationale:
    Mild cognitive impairment and dementia are frequent symptoms of moderate to advanced Parkinson’s disease (PD). Brain positron emission tomography (PET) study findings confirm post...

  • Cognitive Deficits and Mood Disorders in Parkinson's Disease, 2008
    Cognitive Decline in Parkinson's Disease

    Objective/Rationale:
    There are many studies on cognitive and behavioral alterations in Parkinson’s disease, but each of these investigations brought only a small piece of a large puzzle. Consequently...

  • Defining Cognitive Phenotypes of Parkinson's Disease, 2011
    Cognitive Phenotypes in Parkinson's Disease: Anatomical and Functional Correlates

    Objective/Rationale:
    Cognitive impairment with and without dementia is frequent in Parkinson's disease (PD). However, there is a high heterogeneity in the clinical presentation of these cognitive...

  • Defining Cognitive Phenotypes of Parkinson’s Disease, 2011
    Development of Multimodal Imaging Biomarkers for Cognitive Dysfunction in Parkinson's Disease

    Objective/Rationale:
    By the time a person with Parkinson’s disease (PD) meets diagnostic criteria for dementia, the brain has already been ravaged. Unfortunately, current clinical, neuropsychological...

  • Defining Cognitive Phenotypes of Parkinson’s Disease, 2011
    Bioanatomical Phenotype of Parkinson's Disease With and Without Cognitive Impairment

    Objective/Rationale:             
    Mild cognitive impairment (MCI) and dementia are common in Parkinson’s disease. However, presently, it is difficult to recognize which aspects of cognitive changes are...

  • Cognitive Deficits and Mood Disorders in Parkinson's Disease, 2008
    Neuroimaging Markers Predict Cognitive Decline in PD

    Objective/Rationale:
    Isolated cognitive impairments are common in PD; they increase in number and severity with advancing age and motor disability but their relation to the risk of developing dementia...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.